Media Release COPENHAGEN, Denmark; June 6, 2023 Genmab A/S announced today that its Chief Financial Officer Anthony Pagano will participate in a fireside chat at the Goldman Sachs 44th Annual Global. | June 6, 2023
Company Announcement COPENHAGEN, Denmark; May 31, 2023 – Genmab A/S In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this. | May 31, 2023
Oral presentations will highlight epcoritamab-bysp in combination with rituximab-lenalidomide (R2) in high-risk follicular lymphoma Poster presentations will highlight epcoritamab in lymphoma
Company Announcement COPENHAGEN, Denmark; May 23, 2023 – Genmab A/S will increase its share capital by 33,098 shares as a consequence of the exercise of employee warrants. The increase is. | May 23, 2023